Scientific Sessions — Psychiatry Conference 2026
Modern psychiatric practice blends medication management with psychotherapy rather than treating them as
separate tracks. This session looks at how clinicians are combining pharmacological and talk-therapy approaches for
better long-term outcomes, drawing on real case discussions from practicing psychiatrists.
Focus Areas:
- Combined medication-therapy treatment models
- Evidence-based psychotherapy for psychiatric patients
- Patient-centered treatment planning
- Long-term outcome tracking
Genome-guided prescribing is moving from research protocol into everyday psychiatric practice, though the
evidence is still mixed. This session unpacks what pharmacogenomic testing can and can't tell a prescriber today,
and where the science is heading next.
Focus Areas:
- Pharmacogenomic testing in prescribing decisions
- Antidepressant and antipsychotic dosing strategies
- Adverse drug reaction reduction
- Evidence gaps in precision psychiatry
The line between neurology and psychiatry keeps blurring as brain imaging and biomarker research advance. This
session covers how structural and functional brain findings are starting to inform psychiatric diagnosis and treatment
planning.
Focus Areas:
● Neuroimaging in psychiatric diagnosis
● Biomarker-informed treatment
● Overlap between neurological and psychiatric conditions
● Translational neuroscience research
Diagnosing and treating psychiatric conditions in children carries different stakes and different evidence than adult
care. This track focuses on early intervention, developmentally appropriate treatment, and the unique medication
considerations for younger patients.
Focus Areas:
● Early diagnosis and intervention
● Pediatric psychopharmacology
● School and family-based treatment models
● Developmental considerations in diagnosis
An aging population means psychiatric practice increasingly overlaps with dementia care, polypharmacy
management, and late-life mood disorders. This session covers what's changing in how older adults are diagnosed
and treated.
Focus Areas:
● Late-life depression and anxiety
● Dementia-related behavioral symptoms
● Polypharmacy and medication safety in older adults
● Cognitive decline assessment
Substance use disorders rarely show up in isolation from other psychiatric conditions, which makes dual-diagnosis
care one of the field's hardest problems. This session works through current treatment protocols for co-occurring
addiction and mental illness.
Focus Areas:
● Dual diagnosis treatment approaches
● Medication-assisted treatment
● Relapse prevention strategies
● Co-occurring disorder management
Forensic psychiatrists sit at the intersection of clinical practice and the legal system, evaluating competency, risk,
and criminal responsibility. This track covers current standards in forensic evaluation and expert testimony.
Focus Areas:
● Criminal responsibility assessments
● Risk and violence prediction
● Competency evaluations
● Ethics in forensic testimony
Psychiatrists working inside general hospitals manage a different set of problems than outpatient practice —
delirium, medical-psychiatric comorbidity, and rapid-turnaround consults. This session focuses on that inpatient
consultation role.
Focus Areas:
● Delirium recognition and management
● Medical-psychiatric comorbidity
● Inpatient consultation workflows
● Interdisciplinary hospital collaboration
Not every psychiatric intervention happens in a clinic — community-based programs reach patients who'd otherwise
fall through the cracks. This track looks at what's working in public mental health delivery models.
Focus Areas:
● Community-based treatment programs
● Access and equity in psychiatric care
● Public mental health policy
● Outreach to underserved populations
For treatment-resistant cases, neuromodulation is increasingly a first-line option rather than a last resort. This
session reviews current evidence on TMS, ECT, and newer techniques entering clinical use.
Focus Areas:
● Transcranial magnetic stimulation (TMS) protocols
● Electroconvulsive therapy (ECT) updates
● Emerging neuromodulation techniques
● Treatment-resistant depression and psychosis
Remote psychiatric care expanded fast, and the question now is what actually holds up outside emergency
circumstances. This session covers real outcomes data from telepsychiatry programs, not just adoption numbers.
Focus Areas:
● Telepsychiatry outcomes and effectiveness
● Remote prescribing and monitoring
● Technology access barriers
● Regulatory considerations for virtual care
AI tools are being piloted for triage, symptom tracking, and diagnostic support across psychiatric settings, with
wildly different levels of clinical validation. This track separates what's proven from what's still speculative.
Focus Areas:
● AI-assisted diagnostic tools
● Risk-flagging and triage systems
● Clinical validation standards
● Ethical considerations in AI-driven care
Depression and bipolar disorder remain among the most commonly treated psychiatric conditions, yet treatmentresistant cases are still common. This session covers current pharmacological and non-pharmacological approaches
to both.
Focus Areas:
● Treatment-resistant depression
● Bipolar disorder management
● Mood stabilizer prescribing
● Relapse and recurrence prevention
Anxiety and OCD present differently across patients, and treatment response varies widely even with established
protocols. This track reviews both pharmacological and therapeutic strategies currently in use.
Focus Areas:
● Generalized anxiety and panic disorder treatment
● OCD-specific interventions
● Combination medication-therapy approaches
● Treatment-resistant anxiety cases
Long-term management of schizophrenia and related psychotic disorders depends heavily on medication adherence
and relapse prevention. This session looks at long-acting injectables and other strategies supporting sustained
treatment.
Focus Areas:
● Long-acting injectable antipsychotics
● Relapse prevention strategies
● Early psychosis intervention
● Adherence-focused treatment models
Trauma-informed psychiatric care has shifted considerably in the last decade, both in diagnostic framing and
treatment approach. This session covers current evidence-based protocols for PTSD across different patient
populations.
Focus Areas:
● Trauma-informed diagnostic approaches
● PTSD pharmacotherapy
● Evidence-based trauma therapies
● Trauma care in specific populations (veterans, survivors)
Sleep disturbance shows up across nearly every psychiatric diagnosis, yet it's often treated as secondary rather than
addressed directly. This track focuses on sleep as a primary target in psychiatric treatment planning.
Focus Areas:
● Insomnia in psychiatric populations
● Sleep and mood disorder interactions
● Pharmacological sleep interventions
● Behavioral sleep treatment approaches
Eating disorders carry some of the highest mortality rates in psychiatry, making early recognition and coordinated
care especially important. This session covers current diagnostic and treatment standards.
Focus Areas:
● Early recognition and diagnosis
● Medical and psychiatric co-management
● Evidence-based treatment approaches
● Relapse and long-term recovery support
Personality disorders are notoriously difficult to treat within standard psychiatric frameworks, often requiring
longer-term, specialized approaches. This session reviews what's currently working in clinical practice.
Focus Areas:
● Borderline personality disorder treatment
● Dialectical behavior therapy integration
● Long-term treatment planning
● Diagnostic challenges and comorbidity
Suicide risk assessment remains one of the highest-stakes judgment calls in psychiatric practice, and standard tools
don't always predict it well. This track covers current risk assessment and crisis intervention strategies.
Focus Areas:
● Suicide risk assessment tools
● Crisis intervention protocols
● Safety planning approaches
● Post-crisis follow-up care
Psychiatric treatment during pregnancy and postpartum requires balancing maternal mental health against fetal and
infant safety, often with limited research to guide decisions. This session addresses that balance directly.
Focus Areas:
● Perinatal depression and anxiety
● Medication safety during pregnancy and lactation
● Postpartum psychosis management
● Reproductive mental health policy
Physical symptoms with psychiatric roots are common and frequently misdiagnosed in general medical settings.
This track looks at how psychiatric and primary care teams can better identify and manage these cases together.
Focus Areas:
● Somatic symptom disorders
● Psychiatric-primary care collaboration
● Chronic illness and mental health
● Behavioral health integration models
Veterans face a distinct set of psychiatric risk factors, from combat trauma to service-related transition stress, that
general psychiatric training doesn't always cover. This session focuses on care models built specifically for this
population.
Focus Areas:
● Combat-related PTSD
● Veteran-specific treatment programs
● Transition and reintegration mental health
● Suicide prevention among veterans
Diagnostic frameworks built in one cultural context don't always translate cleanly to another, which creates real gaps
in global psychiatric care. This track examines how culture shapes diagnosis, treatment, and patient trust.
Focus Areas:
● Cross-cultural diagnostic considerations
● Global mental health workforce gaps
● Culturally adapted treatment models
● Stigma across different regions
Autism and ADHD increasingly show up in adult psychiatric practice, not just pediatric settings, often complicating
diagnosis in patients who were missed earlier in life. This session covers diagnosis and treatment across the lifespan.
Focus Areas:
● Adult ADHD diagnosis and treatment
● Autism spectrum psychiatric comorbidities
● Lifespan approaches to neurodevelopmental care
● Medication management considerations
Genetic research is starting to reshape how psychiatric risk gets assessed, though clinical application still lags behind
the science. This track reviews current findings and what they actually mean for practice today.
Focus Areas:
● Genetic risk factors in psychiatric illness
● Family history and heritability research
● Clinical application of genetic findings
● Ethical considerations in genetic testing
The search for reliable psychiatric biomarkers has been slow going, but a few promising leads are starting to move
toward clinical use. This session separates genuinely actionable findings from early-stage research.
Focus Areas:
● Blood-based and imaging biomarkers
● Precision treatment matching
● Diagnostic biomarker validation
● Research-to-practice translation
Patients increasingly ask about complementary approaches alongside standard psychiatric treatment, and clinicians
need a clear-eyed view of what actually has evidence behind it. This track covers that evidence directly.
Focus Areas:
● Evidence for complementary interventions
● Nutrition and lifestyle factors in mental health
● Integrating complementary approaches with medication
● Patient-led treatment preferences
Psychiatric care increasingly depends on coordinated teams rather than a single prescriber, with nurses and case
managers carrying much of the day-to-day patient relationship. This session focuses on that team-based model.
Focus Areas:
● Psychiatric nursing scope of practice
● Care coordination across disciplines
● Case management in psychiatric settings
● Team-based treatment planning
The psychiatrist shortage isn't an abstract statistic — it directly shapes what kind of care is even available to patients
in a given region. This closing track covers workforce policy and what's being tried to address the gap.
Focus Areas:
● Psychiatrist workforce shortage solutions
● Reimbursement and insurance policy
● Rural and underserved access initiatives
● Training pipeline expansion
